(PFE) Pfizer - Performance -8.6% in 12m
PFE performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-33.88%
#86 in Peer-Group
Rel. Strength
31.39%
#5096 in Stock-Universe
Total Return 12m
-8.55%
#93 in Peer-Group
Total Return 5y
-1.75%
#66 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 17.6 |
| P/E Forward | 8.30 |
| High / Low | USD |
|---|---|
| 52 Week High | 29.84 USD |
| 52 Week Low | 21.19 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 72.29 |
| Buy/Sell Signal +-5 | -0.68 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance | 27.6, 26.9, 26.2, 25.8, 25.2, 24.3 |
12m Total Return: PFE (-8.6%) vs XLV (-6%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-5.69% | 124% | 337% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
7.32% | -14.6% | 405% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NVS NYSE Novartis |
6.6% | 16.7% | 77.9% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
2.29% | 3% | 48.6% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-3.55% | 4.95% | 48.8% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-7.76% | -5.21% | 112% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| AZN NASDAQ AstraZeneca |
-1.44% | -8.57% | 48.1% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
1.55% | -9.51% | 43.2% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: PFE vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for PFE
| Total Return (including Dividends) | PFE | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 3.16% | 1.67% | 4.52% |
| 3 Months | -2.72% | -7.84% | 10.25% |
| 12 Months | -8.55% | -6.02% | 14.16% |
| 5 Years | -1.75% | 47.32% | 116.91% |
| Trend Score (consistency of price movement) | PFE | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 57% | 41.7% | 79.1% |
| 3 Months | 52.7% | -51% | 91.7% |
| 12 Months | -83.4% | -70.9% | 44% |
| 5 Years | -53.3% | 88% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th64.58 | 1.46% | -1.31% |
| 3 Month | %th41.15 | 5.55% | -11.76% |
| 12 Month | %th51.56 | -2.69% | -19.89% |
| 5 Years | %th64.58 | -33.31% | -54.71% |
FAQs
Does Pfizer (PFE) outperform the market?
No,
over the last 12 months PFE made -8.55%, while its related Sector, the Health Care Sector SPDR (XLV) made -6.02%.
Over the last 3 months PFE made -2.72%, while XLV made -7.84%.
Performance Comparison PFE vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
PFE vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.8% | -1.4% | -10.3% | -23% |
| US NASDAQ 100 | QQQ | -2.4% | -2.4% | -11.7% | -23% |
| German DAX 40 | DAX | -2.6% | 2.8% | -25.5% | -39% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.1% | 0.7% | -6.3% | -25% |
| Hongkong Hang Seng | HSI | -2.1% | -3.7% | -27.5% | -44% |
| India NIFTY 50 | INDA | -2.2% | 0.8% | -11.3% | -9% |
| Brasil Bovespa | EWZ | -1.1% | -0.3% | -31.9% | -19% |
PFE vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3% | -3.7% | -16.6% | -36% |
| Consumer Discretionary | XLY | -1.3% | 1.3% | -2.3% | -29% |
| Consumer Staples | XLP | 1.7% | 4.4% | -9.2% | -17% |
| Energy | XLE | 1.5% | -1.4% | -7.7% | -5% |
| Financial | XLF | -1.5% | 0.7% | -13.5% | -37% |
| Health Care | XLV | -0.7% | 1.5% | -3.6% | -3% |
| Industrial | XLI | -1.4% | 0% | -17.1% | -32% |
| Materials | XLB | -0.4% | 0.8% | -11.1% | -12% |
| Real Estate | XLRE | 2.9% | 3.6% | -8.6% | -20% |
| Technology | XLK | -2.6% | -5.3% | -12.5% | -19% |
| Utilities | XLU | 0.6% | 2.2% | -14% | -32% |
| Aerospace & Defense | XAR | -3.7% | -6.5% | -31.4% | -60% |
| Biotech | XBI | -0.2% | -0% | 2.5% | 2% |
| Homebuilder | XHB | -0.4% | -0.7% | 0.2% | -9% |
| Retail | XRT | 0.4% | 1% | -2.9% | -15% |
PFE vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 4.8% | -5.90% | -3.09% | 2% |
| Natural Gas | UNG | 2.5% | -0.3% | 3.1% | -8% |
| Gold | GLD | 3.8% | 4.6% | -30.3% | -48% |
| Silver | SLV | 1.7% | -4.5% | -28.6% | -30% |
| Copper | CPER | -2.7% | -5.5% | -28.7% | -24% |
PFE vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -0% | 1.3% | -6.5% | -10% |
| iShares High Yield Corp. Bond | HYG | 0.2% | 1.6% | -9.8% | -19% |